Corbus Pharmaceuticals Announces First Patient Dosed in TEMPO-1 Registrational Study of CRB-701 in Patients with 2L+ Oropharyngeal Cancer

Incidence and prevalence of OPSCC continue to rise in the U.S. largely driven by HPV infection OPSCC is estimated to ...
MarketScreener

Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development

We are thrilled to welcome Lucas to the Sutro team at a time of significant momentum across our pipeline, as we build on our encouraging early clinical data with STRO-004, advance STRO-006 in the ...

US waives tariffs on specialty drugs: What will change for India? Explained

The United States (US) has announced zero-tariff treatment for certain specialty pharmaceutical products and their associated ...
Santé log

Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer

Milestone reflects continued progress in collaboration to develop a novel class of degrader antibody conjugates, or DACs ...
BioSpace

BeyondSpring Announces FDA Fast Track Designation for Plinabulin in Post-ICI Non-Squamous NSCLC and Strategic Transaction to Advance Global Phase 3 DUBLIN-4 Trial Toward ...

FLORHAM PARK, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE)-- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage company developing innovative therapies for the treatment of ...